This News From Novo: A Warning for Eli Lilly Shareholders
A GLP-1 drug race is moving from injections to pills, reshaping the landscape for Novo Nordisk and Eli Lilly. Here’s ...
US large, mid, and small-cap retirement index funds provide layered exposure to varying market segments. This intro covers allocation ideas and risk considerations.
26,127 articlesA GLP-1 drug race is moving from injections to pills, reshaping the landscape for Novo Nordisk and Eli Lilly. Here’s ...
The Strategic Petroleum Reserve sits near a 40-year low, yet Wall Street focuses on production and demand signals rat...
A 62-year-old retiree faces the challenge of sustaining $65,000 in annual spending with investment income. This piece...
The dramatic shift policy just signaled by the Fed has set the stage for a new era in healthcare investing. Bristol M...
Rivian shares traded near $14.90 as macro headwinds pressure EV names, while a still-growing VW software venture keep...
Solana’s on-chain data show real-world asset transfers surging to $8.68 billion in the last 30 days, with asset value...
Sweetgreen stock surged today as growth signals and strategic moves raised investor confidence. This guide breaks dow...
Two powerful stories face off in the market: Nike's established dominance vs On's high-growth potential. This guide s...
A Wisconsin man receives a seven-year prison term for arson linked to opposition to a TikTok policy. The case undersc...
TMC jumped on regulatory news, but the road to deep-seabed mining remains lengthy and costly. This guide breaks down ...
Federal regulators are pulling nearly 90,000 bottles of children's ibuprofen from shelves after reports of foreign ma...
As Flotek prepares for its Q3 2025 earnings, investors will parse management tone, margins, and guidance. This articl...